Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 40 out of 100. Digital health tools

Topic: Amyloid, tau and blood-test diagnosis

Aims The study explores how speech measures may be linked to language profiles in participants with Alzheimer's disease (AD) and how these profiles could distinguish AD from changes associated with normal aging. Methods We analysed simple sentences spoken by older adults with and without AD. Spectrographic analysis of temporal and acoustic characteristics was carried out using the Praat software. Results We found that measures of speech, such as variations in the percentage of voice breaks, number of periods of voice, number of voice breaks, shimmer (amplitude perturbation quotient), and noise-to-harmonics ratio, characterise people with AD with an accuracy of 84.8%. Discussion These measures offer a sensitive method of assessing spontaneous speech output in AD, and they discriminate well between people with AD and healthy older adults. This method of evaluation is a promising tool for AD diagnosis and prognosis, and it could be used as a dependent measure in clinical trials.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Meilán, J. J., Martínez-Sánchez, F., Carro, J., López, D. E., Millian-Morell, L., & Arana, J. M. (2014). Speech in Alzheimer's disease: can temporal and acoustic parameters discriminate dementia? Dementia and geriatric cognitive disorders. https://doi.org/10.1159/000356726

Vancouver

Meilán JJ, Martínez-Sánchez F, Carro J, López DE, Millian-Morell L, Arana JM. Speech in Alzheimer's disease: can temporal and acoustic parameters discriminate dementia? Dementia and geriatric cognitive disorders. 2014. doi:10.1159/000356726. PMID: 24481220.

BibTeX

@article{meilan2014-24481220,
  author  = {Meilán, J. J. and Martínez-Sánchez, F. and Carro, J. and López, D. E. and Millian-Morell, L. and Arana, J. M.},
  title   = {{Speech in Alzheimer's disease: can temporal and acoustic parameters discriminate dementia?}},
  journal = {Dementia and geriatric cognitive disorders},
  year    = {2014},
  doi     = {10.1159/000356726},
  pmid    = {24481220},
  url     = {https://doi.org/10.1159/000356726}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

In older adults with and without Alzheimer's disease, measures such as percentage of voice breaks, number of voice periods and breaks, shimmer, and noise-to-harmonics ratio characterized people with Alzheimer's disease with 84.8% accuracy. The authors describe this as a promising tool for diagnosis and prognosis, not for treating, curing, or preventing Alzheimer's disease.

Study details

How this study scored 40/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 1 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 1 of 5; Sample size 0 of 4; Effect reported 2 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 5 of 7; Citations per year 3 of 5; Impact for its field and year 3 of 6; Cited by studies here 1 of 6; Still being cited 2 of 4; Senior author's track record 1 of 4; Institution's track record 0 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 0 of 2. Total 40 of 100.40 of 100 points earned60 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Dementia and geriatric cognitive disorders)
Journal's citation record 1 / 4 Dementia and Geriatric Cognitive Disorders: journal h-index 149 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 1 / 5 2014 — within 20 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 5 / 7 Cited 152 times (OpenAlex, 2026-10-10)
Citations per year 3 / 5 10.9 citations a year over 14 year(s) since 2014
Impact for its field and year 3 / 6 Cited 3.6× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 1 / 6 Cited by 1 other studies in this library
Still being cited 2 / 4 Cited 45 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 1 / 4 Last-listed author José María Arana Martínez: h-index 12 (OpenAlex, whole career)
Institution's track record 0 / 3 Universidad de Salamanca: institution h-index 432 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 2 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 24481220)
Free to read 0 / 2 Behind a paywall — scores zero
Total 40 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Later studies that cite this one

1 study in the alzhub library lists this one in its references.

Related studies in Digital health tools

Also in Digital health tools

178 studies in the library are filed under Digital health tools with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Digital health tools hub.

Similar studies

More on Digital health tools

See all studies in Digital health tools →